BR100 Increased By (1.44%)
BR30 Increased By (1.71%)
KSE100 Increased By (1.14%)
KSE30 Increased By (1.16%)
BECO 5.64 Increased By ▲ 0.05 (0.89%)
BML 62.17 Increased By ▲ 1.14 (1.87%)
BOP 33.83 Increased By ▲ 0.58 (1.74%)
CNERGY 8.16 Increased By ▲ 0.11 (1.37%)
DCL 11.51 Increased By ▲ 0.21 (1.86%)
FCCL 53.85 Increased By ▲ 0.92 (1.74%)
FCSC 5.41 Increased By ▲ 0.07 (1.31%)
FFL 17.85 Increased By ▲ 0.24 (1.36%)
FNEL 1.33 Increased By ▲ 0.02 (1.53%)
HUMNL 11.10 Decreased By ▼ -0.02 (-0.18%)
KEL 8.03 Increased By ▲ 0.14 (1.77%)
KOSM 5.39 Increased By ▲ 0.06 (1.13%)
MLCF 86.70 Increased By ▲ 1.35 (1.58%)
NBP 184.33 Increased By ▲ 3.04 (1.68%)
PACE 11.80 Increased By ▲ 0.27 (2.34%)
PAEL 40.15 Increased By ▲ 0.74 (1.88%)
PIAHCLA 26.03 Increased By ▲ 0.40 (1.56%)
PIBTL 17.40 Increased By ▲ 0.25 (1.46%)
PPL 228.25 Increased By ▲ 3.43 (1.53%)
PRL 34.55 Increased By ▲ 0.37 (1.08%)
PTC 66.42 Increased By ▲ 1.34 (2.06%)
SEARL 91.29 Increased By ▲ 1.69 (1.89%)
SSGC 26.65 Increased By ▲ 0.34 (1.29%)
TELE 8.50 Increased By ▲ 0.12 (1.43%)
THCCL 71.89 Increased By ▲ 2.55 (3.68%)
TPLP 10.90 Increased By ▲ 0.62 (6.03%)
TREET 24.59 Increased By ▲ 0.39 (1.61%)
TRG 70.80 Increased By ▲ 1.26 (1.81%)
WAVES 11.25 Increased By ▲ 0.22 (1.99%)
WTL 1.27 No Change ▼ 0.00 (0%)

ISLAMABAD: Pakistan on Tuesday reported 358 positive cases of coronavirus and eight Covid-19-related deaths across the country.

According to the data released by the National Institute of Health (NIH), a total of 12,273 coronavirus tests were conducted, out of which, 358 returned positive with a positivity rate recorded at 2.92 percent across the country. As many as eight coronavirus-related deaths were also reported while 165 patients are in critical care in the country’s hospitals.

As per the statistics, released by the District Health Office, Islamabad, the positivity rate for the federal capital was recorded at 5.56 percent on August 15. A total of 43 positive cases were reported out of the 773 tests conducted over the past 24 hours.

Copyright Business Recorder, 2022

Comments

Comments are closed for this article.